# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-17-013474
Filing Date
2017-12-20
Accepted
2017-12-20 16:09:47
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | f424b4122017_akersbio.htm | 424B4 | 5804254
2 | GRAPHIC | image001.jpg | GRAPHIC | 21467
3 | GRAPHIC | image002.jpg | GRAPHIC | 445960
| Complete submission text file | 0001213900-17-013474.txt |  | 6449394

Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-221746 | Film No.: 171266867
SIC: 2835 In Vitro & In Vivo Diagnostic Substances